| Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT04815720) | Vaccinex Inc. | 2021-08-09 |
| Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (NCT04704661) | National Cancer Institute (NCI) | 2021-08-09 |
| Pharmacokinetics of Adrenaline After Administration of ARS -1 in Subjects With Upper Respiratory Tract Infection (NCT04930900) | ARS Pharmaceuticals, Inc. | 2021-08-09 |
| Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors (NCT04377932) | Baylor College of Medicine | 2021-08-08 |
| Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC) (NCT04990063) | suhaichuan | 2021-08-08 |
| Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) (NCT05050474) | Livzon Pharmaceutical Group Inc. | 2021-08-07 |
| A Study of NB003 in Patients With Advanced Malignancies (NCT04936178) | Ningbo Newbay Technology Development Co., Ltd | 2021-08-06 |
| A Trial of SHR-A1904 in Patients With Advanced Pancreatic Cancer (NCT04928625) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2021-08-06 |
| A Mass Balance and Biotransformation Study of [14C]SKLB1028 in Chinese Healthy Male Subjects (NCT05369858) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-08-06 |
| Study of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung Cancer (NCT06525246) | Ono Pharmaceutical Co., Ltd. | 2021-08-06 |
| Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine (NCT03762291) | Baylor College of Medicine | 2021-08-06 |
| Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019 (NCT04883528) | Duke University | 2021-08-06 |
| Dosimetry of Tc-99m-Tilmanocept (NCT05241522) | University of California, San Diego | 2021-08-06 |
| A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of mRNA-3705 in Participants With Isolated Methylmalonic Acidemia (NCT04899310) | ModernaTX, Inc. | 2021-08-06 |
| Evaluation of the Pharmacokinetics and Safety of BLU-5937 in Healthy Adult Japanese and Caucasian Subjects (NCT06179537) | Bellus Health Inc. - a GSK company | 2021-08-06 |
| A Trial of Y101D, a PD-L1/TGF-β Bispecific Antibody, in Patients With Metastatic or Locally Advanced Solid Tumors (NCT05028556) | Wuhan YZY Biopharma Co., Ltd. | 2021-08-06 |
| Phase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and Adolescents (NCT04954287) | CyanVac LLC | 2021-08-06 |
| Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy (NCT04497038) | University of Michigan Rogel Cancer Center | 2021-08-06 |
| Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 (NCT04787042) | Simcha IL-18, Inc. | 2021-08-06 |
| Pharmacokinetic and Pharmacodynamic Study of AMX0035 in Patients With ALS (NCT04987671) | Amylyx Pharmaceuticals Inc. | 2021-08-05 |
| Single Ascending Dose Study of SAR443820 in Healthy Adult Chinese and Japanese Female and Male Participants (NCT04982991) | Sanofi | 2021-08-05 |
| Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma (NCT04973098) | Peking University | 2021-08-05 |
| A Study to Evaluate the Effect of Hepatic Impairment on JNJ-42847922 in Adult Participants (NCT04960124) | Janssen Research & Development, LLC | 2021-08-05 |
| A Study in Healthy Japanese Men to Test How Different Doses of BI 1569912 Are Taken up by the Body and How Well They Are Tolerated (NCT04958252) | Boehringer Ingelheim | 2021-08-05 |
| Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC (NCT04470024) | Providence Health & Services | 2021-08-05 |
| A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine (NCT04967742) | United Biomedical Inc., Asia | 2021-08-05 |
| A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors (NCT04913285) | Pierre Fabre Medicament | 2021-08-04 |
| Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer (NCT05218889) | Chinese PLA General Hospital | 2021-08-04 |
| An Investigational Scan (rh PSMA 7.3 PET/MRI) for the Detection of Recurrent Disease and Aid in Radiotherapy Planning in Biochemically Recurrent Prostate Cancer (NCT04978675) | M.D. Anderson Cancer Center | 2021-08-04 |
| Safety and Tolerability of Lu AG06474 in Healthy Young Men (NCT05003687) | H. Lundbeck A/S | 2021-08-04 |
| A Study to Examine the Safety, Tolerability and Biological Effects of Single Doses of Subcutaneously and Intravenously Administered Pozelimab as Monotherapy and in Combination With Single Doses of Subcutaneously Administered Cemdisiran in Adult Japanese Healthy Volunteers (NCT04940364) | Regeneron Pharmaceuticals | 2021-08-04 |
| First-in-human Trial With Single-dose C5a-neutralizing AON-D21 in Healthy Male Subjects (NCT05018403) | Aptarion Biotech AG | 2021-08-03 |
| A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Participants of Childbearing Potential (NCT04934696) | Bristol-Myers Squibb | 2021-08-03 |
| Single and Multiple Ascending Dose Study of CORT125236 in Healthy Participants (NCT05003713) | Corcept Therapeutics | 2021-08-03 |
| To Evaluate a Phase I/II Clinical Study of XNW5004 Tablets in Patients With Relapsed/Refractory Advanced Tumors (NCT06558513) | Evopoint Biosciences Inc. | 2021-08-03 |
| Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years Old (NCT06350058) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2021-08-03 |
| Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants. (NCT04958291) | Celgene | 2021-08-03 |
| Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer (NCT04605731) | City of Hope Medical Center | 2021-08-03 |
| Effect of Acupuncture Plus Governor Vessel Moxibustion Combined With Letrozole on Live Birth in Anovulatory Infertile Women With Spleen-kidney Yang Deficiency PCOS (NCT04987632) | Qiu-ping Lin | 2021-08-03 |
| GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors (NCT04977453) | GI Innovation, Inc. | 2021-08-02 |
| Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma. (NCT05097911) | National University Hospital, Singapore | 2021-08-02 |
| Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma (NCT04935229) | TriSalus Life Sciences, Inc. | 2021-08-02 |
| Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells (NCT03690011) | Baylor College of Medicine | 2021-08-02 |
| A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION. (NCT04971512) | Enanta Pharmaceuticals, Inc | 2021-08-02 |
| APL-102 Capsule in Patients With Advanced Solid Tumors (NCT05055518) | Apollomics Inc. | 2021-08-02 |
| A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against Dengue Virus (NCT04935801) | Gylden Pharma Ltd | 2021-08-02 |
| A Study to Evaluate the Absorption, Metabolism, and Excretion and Absolute Bioavailability of Xevinapant in Healthy Male Participants (NCT04962724) | Debiopharm International SA | 2021-08-02 |
| 28-Day Daily-dose Crossover Study of the Safety and Tolerability of SB-121 (Lactobacillus Reuteri With Sephadex® and Maltose) in Subjects, Ages 15 to 45 Years, Diagnosed With Autistic Disorder (NCT04944901) | Scioto Biosciences, Inc. | 2021-08-02 |
| Effect of Human Umbilical Cord-derived Mesenchymal Stem Cells on Non-cardiac Surgery-induced Lung Injury (NCT04996966) | Shanghai East Hospital | 2021-08-01 |
| Treatment of Cartilage Defects With Peripheral Blood Stem Cells (NCT04953572) | Peking University Third Hospital | 2021-08-01 |
| Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19 (NCT04900454) | Coeptis Therapeutics | 2021-08-01 |
| Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease (NCT05152160) | Shenzhen University General Hospital | 2021-08-01 |
| RAPA-201 Therapy of Solid Tumors (NCT05144698) | Rapa Therapeutics LLC | 2021-08-01 |
| Assessing an Oral Bruton Tyrosine Kinase Inhibitor, DZD9008 in Patients Who Have Non-Hodgkin B-cell Lymphoma (WU-KONG3) (NCT04148742) | Dizal Pharmaceuticals | 2021-08-01 |
| Combination Therapy for First Line Treatment of Advanced Cervical Cancer (NCT04731038) | Ruijin Hospital | 2021-08-01 |
| Hybrid Robot+FES Stroke Rehabilitation (NCT04550728) | University of Maryland, Baltimore | 2021-08-01 |
| Effect of Food on the Pharmacokinetics of XZP-3287 in Healthy Subjects (NCT04951765) | Xuanzhu Biopharmaceutical Co., Ltd. | 2021-08-01 |
| Clinical Trial of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Population Aged 3 to 17 Years(COVID-19) (NCT05003479) | Shenzhen Kangtai Biological Products Co., LTD | 2021-08-01 |
| Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients (NCT05108012) | Royan Institute | 2021-08-01 |
| Evaluating Autologous Stromal Vascular Fraction in Subjects with Vocal Fold Scar (NCT05354544) | Shane A. Shapiro | 2021-08-01 |
| Comparative Usability Evaluation of Sustained Acoustic Medicine (SAM) Devices and Topical Gel for OA Knee Pain (NCT05050448) | ZetrOZ, Inc. | 2021-08-01 |
| CRISPR/Cas9-modified Human T Cell ( PD-1and ACE2 Knockout Engineered T Cells ) for Inducing Long-term Immunity in COVID-19 Patients (NCT04990557) | Mahmoud Ramadan mohamed Elkazzaz | 2021-08-01 |
| Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 3) (NCT04932187) | Ruijin Hospital | 2021-08-01 |
| Hypofraction Radiotherapy for Locally Advanced Non-small Cell Lung Cancer (NCT05269485) | Anhui Provincial Hospital | 2021-08-01 |
| TA-CIN Vaccine With Anti-PD-1 Therapy in Recurrent HPV16-associated Cancers (NCT05132803) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2021-08-01 |
| Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined Immunodeficiency (NCT02860559) | Taiga Biotechnologies, Inc. | 2021-08-01 |
| LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors (NCT04690699) | Istari Oncology, Inc. | 2021-08-01 |
| Phase 1 Trial of the TQB2928 Injection in Patients With Advanced Cancers (NCT04854681) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-08-01 |
| Elucidating Mechanisms That Underlie the Symptomatology of Functional Dyspepsia Using Novel Techniques and Its Therapeutic Validation Using Neuromodulators (NCT06213948) | Universiti Sains Malaysia | 2021-08-01 |
| Trametinib Plus Anlotinib in Non-G12C KRAS-Mutant NSCLC Patients (NCT04967079) | Shanghai Chest Hospital | 2021-08-01 |
| CD19 Targeted CAR T Cell Therapy in Patients With Relapsed/ Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (NCT04653493) | Sabz Biomedicals | 2021-08-01 |
| Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma (NCT04491370) | New York Medical College | 2021-08-01 |
| A Study of Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With Osteosarcoma (NCT04833582) | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | 2021-08-01 |
| Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer (NCT05003752) | German Oncology Center, Cyprus | 2021-08-01 |
| The Phosphodiesterase Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients (NCT05030623) | Sadat City University | 2021-08-01 |
| Effects of Single Dose Tadalafil on Urethral and Anal Closure Function (NCT05095077) | University Hospital Bispebjerg and Frederiksberg | 2021-08-01 |
| Closed-loop Functional Spinal Cord Stimulation in Patients With Spinal Cord Injury (NCT04969042) | Luming Li | 2021-08-01 |
| The Safety and Tolerability of Initial Periodontal Therapy Combined With Human Dental Pulp Stem Cell Injection in the Treatment of Chronic Periodontitis (NCT04983225) | Peking University Third Hospital | 2021-07-31 |
| Relative Bioavailability Study to Assess an LC350189 Tablet Compared to an LC350189 Capsule in Healthy Adults (NCT04886050) | LG Chem | 2021-07-31 |
| Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors (NCT04906473) | Kunming Pharmaceuticals, Inc. | 2021-07-31 |
| Clinical Trial of SARS-CoV-2 mRNA Vaccine in China (NCT05364047) | AIM Vaccine Co., Ltd. | 2021-07-31 |
| A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects. (NCT05191563) | Hanmi Pharmaceutical Company Limited | 2021-07-31 |
| Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19) (NCT04498325) | Washington University School of Medicine | 2021-07-31 |
| A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 3 (NCT04985955) | Janssen Research & Development, LLC | 2021-07-30 |
| PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy (NCT04942301) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2021-07-30 |
| Study of Bevacizumab With Different Manufacturing Process in Healthy Male Subjects (NCT05005455) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-07-30 |
| Intravenous Magnesium in Patients Receiving Cisplatin (NCT04481672) | Dana-Farber Cancer Institute | 2021-07-30 |
| A Study of 177Lu-FAP-2286 in Advanced Solid Tumors (NCT04939610) | Novartis Pharmaceuticals | 2021-07-30 |
| Safety and Tolerability Study With VY-HTT01, in Adults With Early Manifesting Huntington's Disease (NCT04885114) | Voyager Therapeutics | 2021-07-30 |
| Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-723 in Patients With Advanced Solid Tumors (NCT05537987) | InnoCare Pharma Inc. | 2021-07-30 |
| An Open-label, Uncontrolled Study of ONO-7913 and ONO-4538 in Combination With Modified FOLFIRINOX Therapy, the Standard of Care, as First-line Treatment in Patients With Metastatic Pancreatic Cancer (NCT06532344) | Ono Pharmaceutical Co., Ltd. | 2021-07-30 |
| A Study of Mitoxantrone Hydrochloride Liposome Injection in Chinese Patients With Advanced Solid Tumors (NCT04921878) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-07-30 |
| Combination of Duloxetine and Pregabalin to Improve Postoperative Pain (NCT04862845) | Cairo University | 2021-07-30 |
| A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML) (NCT04964518) | Ascentage Pharma Group Inc. | 2021-07-30 |
| Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis (NCT04669158) | Stanford University | 2021-07-30 |
| Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer (NCT04811703) | Hospices Civils de Lyon | 2021-07-30 |
| Single and Multiple Ascending Dose Study of KN-002 (NCT05006521) | Kinaset Therapeutics Inc | 2021-07-30 |
| Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma (NCT04984434) | Shandong New Time Pharmaceutical Co., LTD | 2021-07-30 |
| A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment (NCT04919499) | Boehringer Ingelheim | 2021-07-30 |
| Safety & Efficacy of DC Vaccine and TMZ for the Treatment of Newly-diagnosed Glioblastoma After Surgery (NCT04968366) | Beijing Tiantan Hospital | 2021-07-30 |